Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,488.00
Bid: 2,482.00
Ask: 2,484.00
Change: 28.00 (1.14%)
Spread: 2.00 (0.081%)
Open: 2,465.00
High: 2,497.00
Low: 2,460.00
Prev. Close: 2,460.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Board Changes

31 Aug 2017 07:00

RNS Number : 3648P
British American Tobacco PLC
31 August 2017
 

31 August 2017

 

British American Tobacco

Management Board Changes

 

 

Following the successful completion of the acquisition of Reynolds American Inc. ("Reynolds American"), we have decided to simplify our regional structure and to fully integrate our Next Generation Products ("NGPs") business into the core operations of the Group - reflecting the outstanding growth of this part of our business to date and its long term importance to the Group's future.

 

As previously announced, Debra Crew joined the Management Board as President and CEO of Reynolds American with effect from 27 July 2017, reporting directly to the Chief Executive, Nicandro Durante.

 

We are now pleased to announce that Jack Bowles, Regional Director, Asia-Pacific, will be appointed to the newly created role of Chief Operating Officer for the international business, excluding the United States ("COO"), reporting directly to the Chief Executive, with effect from 1 October 2017. Jack joined the Group in 2004 and has been a member of the Management Board since October 2009.

Our regional organisational structure will be simplified to create the following three new regions:

· Americas and Sub-Saharan Africa (including East & Central Africa; West Africa and South Africa)

· Europe and North Africa (including Russia, Ukraine, Caucasus, Central Asia, Belarus, and Turkey)

· Asia-Pacific and Middle East

Regional Director responsibilities, reporting directly to the COO and continuing as members of the Management Board, will be reorganised as follows, with effect from 1 January 2018:

 

Ricardo Oberlander, Regional Director, Americas, will be appointed Regional Director, Americas and Sub-Saharan Africa. Ricardo joined the BAT Group in 1989 and has been a member of the Management Board since January 2013.

 

Tadeu Marroco, Regional Director, Western Europe, will be appointed Regional Director, Europe and North Africa. Tadeu joined British American Tobacco in Brazil over 20 years ago and has been a member of the Management Board since September 2014.

 

Johan Vandermeulen, Regional Director, EEMEA, will be appointed Regional Director, Asia-Pacific and Middle East. Johan has been with the BAT Group for more than 20 years and joined the Management Board in September 2014.

Now that we have built a successful NGP business which is poised for substantial growth, we will be fully integrating NGP into our existing business infrastructure across the Group - both within the functions and the Regions - to leverage the scale and expertise of the whole Group to drive growth in an area that is fast becoming a key part of our mainstream business. Kingsley Wheaton, Managing Director, Next Generation Products, will manage this integration process.

 

Andrew Gray, Director, Marketing, will be appointed Chief Marketing Officer, reporting directly to the Chief Executive, with effect from 1 October 2017. This expanded role combines the areas of Marketing and R&D, (including Innovation and Product Development) across all categories - combustible cigarettes and NGPs. Andrew has been with the BAT Group for 31 years and has been a member of the Management Board for over 9 years.

 

David O'Reilly, Group Scientific and R&D Director, remains a member of the Management Board, and will report to the Chief Marketing Officer under the new structure.

 

This new structure will enable better, more integrated resource allocation and decision making across geographies and categories. It creates a truly global multi category business, with NGPs embedded at its heart, to drive continued long term success.

 

 

 

ENQUIRIES

 

INVESTOR RELATIONS:

PRESS OFFICE:

Mike Nightingale

Rachael Brierley

+44 20 7845 1180

+44 20 7845 1519

Anna Vickerstaff / Joanne Walia

 

+44 20 7845 2888

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASDLFWSFWSEEA
Date   Source Headline
8th Apr 20211:00 pmRNSDirector/PDMR Shareholding
7th Apr 20215:30 pmRNSDirector/PDMR Shareholding
6th Apr 20213:45 pmRNSDirector/PDMR Shareholding
6th Apr 20213:45 pmRNSDirector/PDMR Shareholding
1st Apr 202111:30 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSBoard Changes and Withdrawal of AGM Resolution
30th Mar 20215:30 pmRNSTR-1: Notification of major holdings
30th Mar 20215:30 pmRNSDirector/PDMR Shareholding
24th Mar 20213:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSDirector/PDMR Shareholding
18th Mar 20216:05 pmRNSPublication of a Prospectus
17th Mar 20218:00 amRNSNotice of AGM
15th Mar 20217:00 amRNSBranch Register: Dividend Finalisation Information
11th Mar 202111:10 amRNSBAT enters strategic R&D collaboration with OGI
9th Mar 20212:00 pmRNSAnnual Financial Report
4th Mar 202112:30 pmRNSDirector/PDMR Shareholding
1st Mar 20212:30 pmRNSTotal Voting Rights
25th Feb 202112:00 pmRNSDirector Declaration
24th Feb 202112:00 pmRNSTR-1: Notification of major holdings
22nd Feb 202111:00 amRNSDirector/PDMR Shareholding
17th Feb 20214:45 pmRNSDirector/PDMR Shareholding
17th Feb 20217:00 amRNSFinal Results
10th Feb 202112:00 pmRNSDirector/PDMR Shareholding
8th Feb 20212:00 pmRNSDirector/PDMR Shareholding
8th Feb 20212:00 pmRNSDirector/PDMR Shareholding
5th Feb 20213:30 pmRNSDirector/PDMR Shareholding
5th Feb 20213:30 pmRNSDirector/PDMR Shareholding
5th Feb 20213:30 pmRNSDirector/PDMR Shareholding
5th Feb 20213:30 pmRNSDirector/PDMR Shareholding
4th Feb 20215:15 pmRNSDirector/PDMR Shareholding
1st Feb 20213:15 pmRNSTotal Voting Rights
29th Jan 20214:15 pmRNSDirector Declaration
19th Jan 20217:00 amRNSBAT announces succession for Director, Operations
15th Jan 20212:30 pmRNSHolding(s) in Company
15th Jan 20217:00 amRNSSFO Closes Investigation Into BAT
13th Jan 202112:30 pmRNSDirector/PDMR Shareholding
8th Jan 202111:45 amRNSDirector/PDMR Shareholding
8th Jan 202110:45 amRNSDirector/PDMR Shareholding
4th Jan 20214:50 pmRNSBlock listing Interim Review
4th Jan 202112:30 pmRNSTotal Voting Rights
24th Dec 202011:25 amRNSDirector/PDMR Shareholding
24th Dec 202011:25 amRNSDirector/PDMR Shareholding
16th Dec 20201:30 pmRNSDirector/PDMR Shareholding
16th Dec 20201:30 pmRNSDirector/PDMR Shareholding
16th Dec 20201:30 pmRNSDirector/PDMR Shareholding
14th Dec 20204:30 pmRNSTR-1: Notification of major holdings
11th Dec 202012:30 pmRNSDirector Declaration
11th Dec 202012:30 pmRNSDirector/PDMR Shareholding
9th Dec 20207:00 amRNS2020 Second Half Pre-Close Trading Update
7th Dec 20204:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.